Clearmind Medicine公司在美国站点进行的FDA批准Cmnd-100 I/Iia期酒精使用障碍临床试验取得积极进展

美股速递
Mar 19

Clearmind Medicine公司宣布,其针对酒精使用障碍的Cmnd-100 I/Iia期临床试验在美国各研究中心进展顺利。这项获得美国食品药品监督管理局批准的研究,目前正在成功推进参与者的治疗工作。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10